These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
575 related articles for article (PubMed ID: 31229495)
1. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495 [TBL] [Abstract][Full Text] [Related]
2. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer. Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis. Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109 [TBL] [Abstract][Full Text] [Related]
4. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis. Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892 [TBL] [Abstract][Full Text] [Related]
5. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408 [TBL] [Abstract][Full Text] [Related]
6. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression. Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606 [TBL] [Abstract][Full Text] [Related]
7. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors. Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859 [TBL] [Abstract][Full Text] [Related]
9. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia. Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313 [TBL] [Abstract][Full Text] [Related]
10. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation. Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438 [TBL] [Abstract][Full Text] [Related]
11. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury. Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais. Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166 [TBL] [Abstract][Full Text] [Related]
13. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002 [TBL] [Abstract][Full Text] [Related]
14. Distribution of killer cell immunoglobulin-like receptors in the Greek population. Niokou D; Spyropoulou-Vlachou M; Darlamitsou A; Stavropoulos-Giokas C Hum Immunol; 2003 Dec; 64(12):1167-76. PubMed ID: 14630399 [TBL] [Abstract][Full Text] [Related]
15. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease. Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240 [TBL] [Abstract][Full Text] [Related]
16. HLA and KIR polymorphisms affect NK-cell anti-tumor activity. Passweg JR; Huard B; Tiercy JM; Roosnek E Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623 [TBL] [Abstract][Full Text] [Related]
17. Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients. Mousavi T; Shahsavar F; Farnia P; Tajik N; Soofi M Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):189-94. PubMed ID: 21891825 [TBL] [Abstract][Full Text] [Related]
18. Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies. Varbanova V; Naumova E; Mihaylova A Cancer Immunol Immunother; 2016 Apr; 65(4):427-40. PubMed ID: 26874942 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]